中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/12/29 | 5,373 | 5,414 | 5,295 | 5,342 | -44 | -0.8% | 1,603,000 |
| 2023/12/28 | 5,344 | 5,401 | 5,298 | 5,386 | +2 | ±0% | 1,051,400 |
| 2023/12/27 | 5,357 | 5,423 | 5,330 | 5,384 | +29 | +0.5% | 1,932,400 |
| 2023/12/26 | 5,349 | 5,364 | 5,305 | 5,355 | +6 | +0.1% | 1,144,600 |
| 2023/12/25 | 5,338 | 5,370 | 5,304 | 5,349 | +34 | +0.6% | 727,000 |
| 2023/12/22 | 5,276 | 5,342 | 5,246 | 5,315 | +20 | +0.4% | 1,631,600 |
| 2023/12/21 | 5,367 | 5,381 | 5,277 | 5,295 | -155 | -2.8% | 1,653,500 |
| 2023/12/20 | 5,333 | 5,487 | 5,322 | 5,450 | +117 | +2.2% | 2,060,800 |
| 2023/12/19 | 5,326 | 5,344 | 5,241 | 5,333 | +29 | +0.5% | 1,978,600 |
| 2023/12/18 | 5,278 | 5,354 | 5,248 | 5,304 | -40 | -0.7% | 1,584,800 |
| 2023/12/15 | 5,362 | 5,449 | 5,297 | 5,344 | -64 | -1.2% | 2,815,500 |
| 2023/12/14 | 5,396 | 5,429 | 5,366 | 5,408 | +71 | +1.3% | 2,098,900 |
| 2023/12/13 | 5,364 | 5,374 | 5,275 | 5,337 | -20 | -0.4% | 2,597,600 |
| 2023/12/12 | 5,347 | 5,428 | 5,330 | 5,357 | +1 | ±0% | 2,324,000 |
| 2023/12/11 | 5,400 | 5,455 | 5,344 | 5,356 | -10 | -0.2% | 1,857,100 |
| 2023/12/08 | 5,405 | 5,426 | 5,314 | 5,366 | -75 | -1.4% | 3,618,400 |
| 2023/12/07 | 5,430 | 5,449 | 5,370 | 5,441 | +1 | ±0% | 2,214,300 |
| 2023/12/06 | 5,297 | 5,440 | 5,281 | 5,440 | +206 | +3.9% | 2,333,100 |
| 2023/12/05 | 5,288 | 5,305 | 5,221 | 5,234 | -87 | -1.6% | 1,919,600 |
| 2023/12/04 | 5,121 | 5,321 | 5,101 | 5,321 | +112 | +2.2% | 2,614,100 |
| 2023/12/01 | 5,244 | 5,293 | 5,197 | 5,209 | -9 | -0.2% | 1,690,400 |
| 2023/11/30 | 5,068 | 5,238 | 5,052 | 5,218 | +150 | +3% | 5,052,900 |
| 2023/11/29 | 5,008 | 5,082 | 4,989 | 5,068 | +54 | +1.1% | 1,495,600 |
| 2023/11/28 | 4,989 | 5,019 | 4,919 | 5,014 | +14 | +0.3% | 2,066,700 |
| 2023/11/27 | 5,091 | 5,094 | 4,962 | 5,000 | -73 | -1.4% | 1,786,400 |
| 2023/11/24 | 5,000 | 5,105 | 5,000 | 5,073 | +133 | +2.7% | 2,942,000 |
| 2023/11/22 | 4,850 | 4,978 | 4,835 | 4,940 | +104 | +2.2% | 2,071,100 |
| 2023/11/21 | 4,856 | 4,876 | 4,770 | 4,836 | -44 | -0.9% | 2,695,400 |
| 2023/11/20 | 4,890 | 4,930 | 4,870 | 4,880 | -23 | -0.5% | 1,928,900 |
| 2023/11/17 | 4,749 | 4,906 | 4,745 | 4,903 | +148 | +3.1% | 2,434,100 |
| 2023/11/16 | 4,718 | 4,755 | 4,690 | 4,755 | +12 | +0.3% | 2,194,000 |
| 2023/11/15 | 4,761 | 4,787 | 4,680 | 4,743 | +36 | +0.8% | 2,422,500 |
| 2023/11/14 | 4,746 | 4,749 | 4,651 | 4,707 | -13 | -0.3% | 1,541,800 |
| 2023/11/13 | 4,716 | 4,743 | 4,672 | 4,720 | +42 | +0.9% | 1,614,200 |
| 2023/11/10 | 4,708 | 4,729 | 4,603 | 4,678 | -91 | -1.9% | 2,241,700 |
| 2023/11/09 | 4,668 | 4,782 | 4,636 | 4,769 | +116 | +2.5% | 2,158,700 |
| 2023/11/08 | 4,667 | 4,727 | 4,634 | 4,653 | +1 | ±0% | 3,100,800 |
| 2023/11/07 | 4,670 | 4,719 | 4,635 | 4,652 | -37 | -0.8% | 1,842,700 |
| 2023/11/06 | 4,708 | 4,719 | 4,654 | 4,689 | +72 | +1.6% | 2,213,700 |
| 2023/11/02 | 4,604 | 4,640 | 4,578 | 4,617 | -9 | -0.2% | 1,568,800 |
| 2023/11/01 | 4,592 | 4,639 | 4,564 | 4,626 | +166 | +3.7% | 2,215,300 |
| 2023/10/31 | 4,358 | 4,475 | 4,331 | 4,460 | +108 | +2.5% | 2,236,100 |
| 2023/10/30 | 4,409 | 4,435 | 4,259 | 4,352 | -116 | -2.6% | 1,837,300 |
| 2023/10/27 | 4,244 | 4,487 | 4,234 | 4,468 | +143 | +3.3% | 2,278,800 |
| 2023/10/26 | 4,408 | 4,446 | 4,306 | 4,325 | -83 | -1.9% | 2,365,700 |
| 2023/10/25 | 4,451 | 4,528 | 4,398 | 4,408 | +9 | +0.2% | 2,635,800 |
| 2023/10/24 | 4,475 | 4,488 | 4,325 | 4,399 | -120 | -2.7% | 2,190,900 |
| 2023/10/23 | 4,548 | 4,556 | 4,489 | 4,519 | -29 | -0.6% | 1,548,900 |
| 2023/10/20 | 4,575 | 4,595 | 4,502 | 4,548 | -65 | -1.4% | 2,110,700 |
| 2023/10/19 | 4,617 | 4,698 | 4,593 | 4,613 | -48 | -1% | 1,783,900 |
401～
450
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 630,000円 | +1.7% | +5.0% | 3.97% | 25.29倍 | 5.22倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 武 田 | 453,300円 | -1.1% | +75.3% | 4.41% | 31.40倍 | 1.03倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 371,000円 | +6.0% | +4.0% | 2.10% | 22.89倍 | 4.23倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 大塚ＨＤ | 800,400円 | +2.2% | +28.0% | 1.75% | 12.81倍 | 1.55倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 167,700円 | +0.9% | +380.2% | 4.65% | 23.10倍 | 1.99倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
